|
| |
Recent News |
|
|
|
|
|
June 10, 2008 |
|
|
May 23, 2008 |
|
|
April 24, 2008 |
|
|
January 31, 2008 |
|
|
January 16, 2008 |
|
|
December 1, 2007 |
|
|
November 15, 2007 |
|
|
October 26, 2007 |
|
|
September 25, 2007 |
|
|
September 21, 2007 |
|
|
|
|
|
|
If you would like to subscribe for our newsletter, please enter your email here |
|
|
|
|
Created by: AeroWeb
Boston Web Design - Web Hosting
|
|
 |
September 21, 2007 - Cure Lab Inc. submits a provisional patent application for a novel molecular adjuvant.
This adjuvant constitutes a new class of protein motifs not previously tested for augmentation of vaccine immunogenicity. A DNA vaccine consisting of the gene encoding the adjuvant fused with the gene encoding for a target antigen has been shown to increase the immune response to the antigen.
|
|
|
|
|
|
|
Cure Lab, Inc. 216 Bolivar Street Canton, MA 02021
| Tel: 781-821-0111 |
|
|
|
